PR Newswire BiotechOriginal article
Resonant Clinical Solutions Expands Global Equipment & Ancillaries Business with Acquisition of Labfish
Positive
AI Analysis
Summary
Resonant Clinical Solutions acquired Labfish to expand its global equipment and ancillaries business, strengthening its European presence and adding specialized calibration expertise and clinical trial support capabilities.
Importance:5/10
Sentiment:
0.60
M&AEquipmentClinical Trial ServicesEuropean ExpansionCalibration Services
Related Companies
Read the original article
Published by PR Newswire Biotech on September 30, 2026 1:28 PM
